Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer

Clinical characteristics of clear cell carcinoma of the ovary

Toru Sugiyama, Toshiharu Kamura, Junzo Kigawa et al. · Cancer · 2000 · 804 citations

Medicine, Oncology, Pathology +14

Toward the development of a universal grading system for ovarian epithelial carcinoma

Yoshio Shimizu, Seiryu Kamoi, Satoshi Amada et al. · Cancer · 1998 · 257 citations · Full text

Veterinary Medicine, Oncology, Pathology +14

The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian Cancer

Amin Makar, M. Baekelandt, Claes O. Tropé et al. · Gynecologic Oncology · 1995 · 223 citations

Medicine, Oncology, Pathology +17

Gain-of-function mutations in the tumor suppressor gene p53.

M G van Oijen, P. J. Slootweg · PubMed · 2000 · 195 citations

Medicine, Cancer Biology, Oncology +15

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.

A. G. van der Zee, H. Hollema, Albert J.H. Suurmeijer et al. · Journal of Clinical Oncology · 1995 · 189 citations

Medicine, Gynecology, Oncology +16